To become a leading global pharmaceutical company. In next 5 years Arinna aims to achieve a turnover of ₹500 CR with having operations in therapy segments of CNS, CVD, Gynecology, Dermatology and Respiratory. In long-run Arinna aims to be leader in therapy segments of CNS, CVD & Dermatology.